NCT05320380 2023-09-01A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatChildren's Oncology GroupPhase 1/2 Withdrawn
NCT03602898 2021-06-30Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Withdrawn